VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 157 filers reported holding VIKING THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $75,000 | +13.6% | 12,000 | +9.1% | 0.01% | +50.0% |
Q2 2021 | $66,000 | -20.5% | 11,000 | -16.7% | 0.00% | -33.3% |
Q1 2021 | $83,000 | -36.6% | 13,200 | -43.2% | 0.01% | -45.5% |
Q4 2020 | $131,000 | -3.0% | 23,225 | 0.0% | 0.01% | -21.4% |
Q3 2020 | $135,000 | -19.2% | 23,225 | 0.0% | 0.01% | -39.1% |
Q2 2020 | $167,000 | +53.2% | 23,225 | 0.0% | 0.02% | +43.8% |
Q1 2020 | $109,000 | -41.4% | 23,225 | 0.0% | 0.02% | -27.3% |
Q4 2019 | $186,000 | +16.2% | 23,225 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $160,000 | -17.1% | 23,225 | 0.0% | 0.02% | -21.4% |
Q2 2019 | $193,000 | -16.5% | 23,225 | 0.0% | 0.03% | -26.3% |
Q1 2019 | $231,000 | +29.8% | 23,225 | -0.4% | 0.04% | +11.8% |
Q4 2018 | $178,000 | -40.7% | 23,325 | +35.4% | 0.03% | -47.7% |
Q3 2018 | $300,000 | +114.3% | 17,225 | +17.0% | 0.06% | +80.6% |
Q2 2018 | $140,000 | +174.5% | 14,725 | +25.6% | 0.04% | +157.1% |
Q1 2018 | $51,000 | -15.0% | 11,725 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $60,000 | – | 11,725 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |